Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioMeter was an Israeli medical device company that specialized in the development of non-invasive hemodynamic monitoring systems. The company's primary product, also named CardioMeter, was designed to provide continuous, real-time measurements of cardiac output and other vital cardiovascular parameters without the need for invasive catheters. Utilizing proprietary sensor technology, the device aimed to improve patient management in critical care, emergency medicine, and surgical settings by offering a safer alternative to traditional thermodilution methods. Despite achieving regulatory milestones and clinical validation, the company is no longer active in its original form.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioMeter.